Denileukin diftitox Terminated Phase 2 Trials for Extraovarian Peritoneal Cancer / Fallopian Tube Carcinoma / Ovarian Epithelial Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01773889A Trial of Intravenous Denileukin Diftitox Plus Subcutaneous Pegylated IFN╬▒-2A in Stage III or IV Ovarian Cancer